Pharmaceutical Grade Lactose PGN-001

Description

1. Product Overview

Pharmaceutical Grade Lactose PGN-001 is a high-purity excipient manufactured from refined milk-derived lactose, specifically processed to meet stringent pharmaceutical industry requirements. It is widely used as a functional ingredient in tablet formulations, capsule production, and dry powder inhalation systems due to its excellent compressibility, flow properties, and compatibility with active pharmaceutical ingredients (APIs). With consistent quality, controlled particle characteristics, and reliable performance, PGN-001 supports efficient drug manufacturing processes and enhanced formulation stability. Its strategic importance lies in its role as a critical pharmaceutical excipient enabling scalable, high-quality production across global healthcare markets.

2. Key Specifications & Technical Characteristics

• Chemical Composition: Lactose monohydrate (C₁₂H₂₂O₁₁·H₂O) derived from purified pharmaceutical-grade milk sugar
• Grade: Pharmaceutical Grade (USP/NF, EP, JP compliant depending on specification requirements)
• Purity Level: High-purity excipient grade with controlled impurities and microbiological limits
• Physical Form: White to off-white crystalline powder or granulated solid
• Particle Size: Available in controlled particle size distributions for direct compression, blending, and inhalation applications
• Solubility: Freely soluble in water with excellent formulation compatibility
• Moisture Content: Controlled moisture level to ensure stability and manufacturing consistency
• Flow Properties: Optimized flowability and compressibility for automated pharmaceutical processing
• Packaging Options: 25 kg pharmaceutical-grade bags, multi-layer moisture-resistant bags, or customized bulk packaging
• Shelf Life: Typically 24–36 months when stored in dry, cool conditions away from direct moisture exposure

3. Core Industrial Applications

• Pharmaceutical Manufacturing: Used as a diluent, filler, and carrier in tablet and capsule formulations to improve powder handling and dosage uniformity.
• Dry Powder Inhalers (DPIs): Functions as a carrier material that enhances aerosol delivery performance and ensures consistent API dispersion.
• Nutraceutical Production: Applied in premium supplement formulations requiring pharmaceutical-quality excipients.
• Research & Development: Supports formulation trials and scale-up production for new pharmaceutical products.

Pharmaceutical Grade Lactose PGN-001 provides superior formulation performance compared with standard lactose grades through controlled particle size, high purity, excellent compressibility, and reliable batch-to-batch consistency. These properties help manufacturers improve production efficiency, reduce formulation risks, and achieve consistent final product quality.

4. Competitive Advantages

• Quality Consistency: Manufactured under strict pharmaceutical quality controls to ensure reliable purity, functionality, and compliance performance.
• Supply Reliability: Supported by robust production capacity and dependable sourcing networks for continuous pharmaceutical manufacturing needs.
• Logistics Capability: Available in export-ready packaging with optimized bulk shipment solutions for global pharmaceutical supply chains.
• Price Competitiveness: Delivers strong value through efficient production processes while maintaining pharmaceutical-grade standards.
• Sustainability Benefits: Derived from renewable dairy-based resources with optimized processing efficiency and responsible manufacturing practices.
• Technical Support & Documentation: Available with full technical documentation, including Certificate of Analysis (COA), Safety Data Sheet (SDS), quality certifications, and regulatory support documentation.

5. Commercial & Supply Information

• Minimum Order Quantity (MOQ): BULK 20MT
• Loading Capacity: Approximately 20 MT per 20-foot container (subject to packaging configuration and shipping requirements)